1. Home
  2. SAMG vs CRBP Comparison

SAMG vs CRBP Comparison

Compare SAMG & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • CRBP
  • Stock Information
  • Founded
  • SAMG 2002
  • CRBP 2009
  • Country
  • SAMG United States
  • CRBP United States
  • Employees
  • SAMG N/A
  • CRBP 19
  • Industry
  • SAMG Investment Managers
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAMG Finance
  • CRBP Health Care
  • Exchange
  • SAMG Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • SAMG 171.2M
  • CRBP 158.3M
  • IPO Year
  • SAMG 2013
  • CRBP N/A
  • Fundamental
  • Price
  • SAMG $17.76
  • CRBP $13.00
  • Analyst Decision
  • SAMG
  • CRBP Strong Buy
  • Analyst Count
  • SAMG 0
  • CRBP 8
  • Target Price
  • SAMG N/A
  • CRBP $62.00
  • AVG Volume (30 Days)
  • SAMG 27.8K
  • CRBP 313.3K
  • Earning Date
  • SAMG 10-31-2024
  • CRBP 11-07-2024
  • Dividend Yield
  • SAMG 4.29%
  • CRBP N/A
  • EPS Growth
  • SAMG N/A
  • CRBP N/A
  • EPS
  • SAMG 0.79
  • CRBP N/A
  • Revenue
  • SAMG $120,231,000.00
  • CRBP N/A
  • Revenue This Year
  • SAMG $7.36
  • CRBP N/A
  • Revenue Next Year
  • SAMG $6.62
  • CRBP N/A
  • P/E Ratio
  • SAMG $23.59
  • CRBP N/A
  • Revenue Growth
  • SAMG 2.45
  • CRBP N/A
  • 52 Week Low
  • SAMG $13.93
  • CRBP $5.25
  • 52 Week High
  • SAMG $19.20
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 45.30
  • CRBP 25.10
  • Support Level
  • SAMG $17.34
  • CRBP $12.90
  • Resistance Level
  • SAMG $18.67
  • CRBP $16.21
  • Average True Range (ATR)
  • SAMG 0.50
  • CRBP 0.95
  • MACD
  • SAMG -0.09
  • CRBP -0.16
  • Stochastic Oscillator
  • SAMG 12.90
  • CRBP 1.69

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: